ANTIBACTERIAL INNOVATIONS: TYPES, ADVANTAGES, AND DISADVANTAGES

Authors

  • Muhammadova Mumina Bakhodirovna,Jalolova Madina Madaminjanovna Andijan Branch of Kokand University Faculty of Medicine Program: General Medicine Year: 2nd year, Group 24–37,

DOI:

https://doi.org/10.55640/

Keywords:

antibacterial innovations, antibiotic resistance, novel antibiotics, bacteriophages, nanoparticles, infection control, therapeutic strategies. Annotatsiya

Abstract

Antibacterial innovations play a critical role in modern medicine by providing new approaches to combat bacterial infections, especially in the era of increasing antibiotic resistance [3, 7, 10]. These innovations include the development of novel antibiotics, antibacterial coatings, nanoparticles, bacteriophages, and combination therapies [1, 2, 4, 5, 6]. Each type of antibacterial technology offers distinct advantages, such as enhanced efficacy, targeted action, reduced side effects, and the ability to overcome multidrug-resistant bacteria [1, 5, 6, 8]. However, challenges and disadvantages remain, including high development costs, potential toxicity, regulatory hurdles, and the risk of bacterial adaptation over time [3, 7, 10]. Understanding the types, advantages, and limitations of antibacterial innovations is essential for researchers, clinicians, and healthcare policymakers to implement effective strategies for infection control and improve patient outcomes [5, 10]. This study aims to provide a comprehensive overview of current antibacterial innovations, their practical applications, and the future prospects of antibacterial therapy [1, 7].

Downloads

Download data is not yet available.

References

1.Abedon, S. T., García, P., Mullany, P., & Aminov, R. (2017). Phage therapy: Past, present and future. Frontiers in Microbiology, 8, 981. https://doi.org/10.3389/fmicb.2017.00981

2.Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., et al. (2019). Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nature Medicine, 25(5), 730–733. https://doi.org/10.1038/s41591-019-0437-z

3.Fair, R. J., & Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspectives in Medicinal Chemistry, 6, 25–64. https://doi.org/10.4137/PMC.S14459

4.Hetrick, E. M., & Schoenfisch, M. H. (2006). Reducing implant-related infections: Active release strategies. Chemical Society Reviews, 35(9), 780–789. https://doi.org/10.1039/B512906H

5.Kaur, I. P., Chopra, K., & Saini, A. (2019). Nanoparticles as novel antimicrobial agents: Emerging trends and future prospects. Journal of Controlled Release, 293, 119–138. https://doi.org/10.1016/j.jconrel.2018.11.021

6.Rai, M., Deshmukh, S. D., Ingle, A. P., & Gade, A. K. (2012). Silver nanoparticles: The powerful nanoweapon against multidrug-resistant bacteria. Journal of Applied Microbiology, 112(5), 841–852. https://doi.org/10.1111/j.1365-2672.2012.05253.x

7.Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and threats. P & T: A Peer-Reviewed Journal for Formulary Management, 40(4), 277–283.

8.Lu, T., Zhao, H., & Wu, X. (2020). Antibacterial coatings for medical devices: Recent advances and future perspectives. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 108(8), 2940–2953. https://doi.org/10.1002/jbm.b.34618

9.Chen, X., Schluesener, H. J. (2008). Nanosilver: A nanoproduct in medical application. Toxicology Letters, 176(1), 1–12. https://doi.org/10.1016/j.toxlet.2007.09.010

10.Ventola, C. L. (2015). The antibiotic resistance crisis: Part 2: Management strategies and new agents. P & T: A Peer-Reviewed Journal for Formulary Management, 40(5), 344–352.

Downloads

Published

2026-02-10

Issue

Vol. 5 No. 02 (2026): Journal of Multidisciplinary Sciences and Innovations

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

ANTIBACTERIAL INNOVATIONS: TYPES, ADVANTAGES, AND DISADVANTAGES. (2026). Journal of Multidisciplinary Sciences and Innovations, 5(02), 707-712. https://doi.org/10.55640/

Similar Articles

1-10 of 1212

You may also start an advanced similarity search for this article.